Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director
|
|
OSIRIS THERAPEUTICS, INC. (OSIR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/17/2019 |
4
| FRIEDLI PETER (Director) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 10,204,404 shares
@ $19, valued at
$193.9M
Disposed/sold 4,103,301 shares
@ $19, valued at
$78M
Disposed/sold 500,000 shares
@ $19, valued at
$9.5M
Disposed/sold 2,750 shares
@ $19, valued at
$52.3k
|
|
| 04/17/2019 |
4
| Keefer Jason (Chief Commercial Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 4,000 shares
@ $19, valued at
$76k
Disposed/sold 16,000 options to buy
@ $6.8, valued at
$108.8k
Disposed/sold 20,000 options to buy
@ $10.53, valued at
$210.6k
|
|
| 04/17/2019 |
4
| Danilkovitch Alla (Chief Scientific Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 9,375 shares
@ $19, valued at
$178.1k
Disposed/sold 8,000 options to buy
@ $7.74, valued at
$61.9k
Disposed/sold 5,000 options to buy
@ $6.46, valued at
$32.3k
Disposed/sold 9,000 options to buy
@ $7.13, valued at
$64.2k
Disposed/sold 6,000 options to buy
@ $5.08, valued at
$30.5k
Disposed/sold 10,000 options to buy
@ $7.73, valued at
$77.3k
Disposed/sold 1,436 options to buy
@ $14, valued at
$20.1k
Disposed/sold 18,564 options to buy
@ $14, valued at
$259.9k
Disposed/sold 7,644 options to buy
@ $18.4, valued at
$140.6k
Disposed/sold 17,356 options to buy
@ $18.4, valued at
$319.4k
Disposed/sold 24,997 options to buy
@ $6.8, valued at
$170k
|
|
| 07/25/2018 |
4
| VENTURETEC INC (BENEFICIAL OWNER) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed of 3,000,000 shares
@ $0 |
|
| 07/09/2018 |
4
| VENTURETEC INC (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed of 1,103,301 shares
@ $0 |
|
| 06/28/2018 |
4
| Keefer Jason (Interim President and CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $10.53, valued at
$210.6k
|
|
| 03/08/2018 |
4
| VERNAL SHAUNA L (Chief Legal Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $8.95, valued at
$179k
|
|
| 03/08/2018 |
4
| CHANG LINDA L (CFO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $8.95, valued at
$89.5k
|
|
| 02/28/2018 |
4
| CHANG LINDA L (CFO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $8.92, valued at
$178.4k
|
|
| 09/28/2017 |
4
| Danilkovitch Alla (Chief Scientific Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 34,534 options to buy
@ $6.8, valued at
$234.8k
Granted 15,466 options to buy
@ $6.8, valued at
$105.2k
|
|
| 09/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2017 |
4
| Avendano Rodrigo Alberto (Chief Medical Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 01/26/2017 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 01/24/2017 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 01/17/2017 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 10/11/2016 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 09/12/2016 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 08/10/2016 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 07/11/2016 |
4
| DRESNER DAVID A (Interim President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 5,000 options to buy
@ $5.03, valued at
$25.2k
|
|
| 06/13/2016 |
4
| Montgomery Bobby Dwayne (CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 6,250 options to buy
@ $12.39, valued at
$77.4k
Disposed/sold 3,125 options to buy
@ $18.4, valued at
$57.5k
Disposed/sold 2,500 options to buy
@ $7.39, valued at
$18.5k
|
|
| 04/14/2016 |
4
| Hopper Jonathan Mark (Chief Medical Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 6,250 options to buy
@ $13.12, valued at
$82k
|
|
| 03/14/2016 |
4
| Czworka Frank D Jr (Vice President) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 3,750 options to buy
@ $5.08, valued at
$19.1k
Disposed/sold 5,000 options to buy
@ $7.73, valued at
$38.7k
Disposed/sold 9,430 options to buy
@ $15.58, valued at
$146.9k
Disposed/sold 13,070 options to buy
@ $15.58, valued at
$203.6k
Disposed/sold 13,316 options to buy
@ $18.4, valued at
$245k
Disposed/sold 5,434 options to buy
@ $18.4, valued at
$100k
|
|
| 03/07/2016 |
4
| Montgomery Bobby Dwayne (CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $7.39, valued at
$73.9k
|
|
| 02/24/2016 |
4
| Debrabandere Lode (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 01/08/2016 |
4
| JACOBY PHILIP R JR (Principal Accounting Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 11/20/2015 |
4
| Debrabandere Lode (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 11/20/2015 |
4
| Danilkovitch Alla (Chief Scientific Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Exercised 4,000 options to buy
@ $5.08, valued at
$20.3k
|
|
| 08/11/2015 |
4
| Danilkovitch Alla (Chief Scientific Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Sold 2,425 shares
@ $18.22, valued at
$44.2k
Exercised 5,000 options to buy
@ $0.4, valued at
$2k
|
|
| 06/08/2015 |
4
| LAW GREGORY IVAN (Principal Accounting Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Bought 100 shares
@ $18.83, valued at
$1.9k
|
|
| 05/29/2015 |
4
| JACOBY PHILIP R JR (CFO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 03/09/2015 |
4
| Czworka Frank D Jr (Vice President) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 5,434 options to buy
@ $18.4, valued at
$100k
Granted 19,566 options to buy
@ $18.4, valued at
$360k
|
|
| 03/09/2015 |
4
| Debrabandere Lode (President & CEO) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 10/02/2014 |
4
| Neumayer Matthew Paul (Principal Accounting Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 05/30/2014 |
4
| Neumayer Matthew Paul (Principal Accounting Officer) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
|
|
|